BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTX) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 3 transactions totaling $2.3M, demonstrating a bullish sentiment with $2.3M in net insider flow. The most recent transaction on May 14, 2024 involved a purchase of 902,935 shares valued at $2.0M.
BCTX Insider Activity Summary
Who Is Buying BCTX Stock?
No significant insider buying has been recorded for BCTX in the recent period.
Who Is Selling BCTX Stock?
No significant insider selling has been recorded for BCTX in the recent period.
Is BriaCell Therapeutics Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BCTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BCTX Frequently Asked Questions
Understanding BCTX Insider Activity
Insider trading at BriaCell Therapeutics Corp. (BCTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading BCTX stock, having executed 3 transactions in the past 90 days. The most active insider is Marc Lustig (Executive), who has made 1 transactions totaling $2.0M.
Related Tools
Track BriaCell Therapeutics Corp. Insider Activity
Get notified when executives and directors at BCTX file new Form 4 transactions